Hemodynamic response and oxygen transport in pigs resuscitated with maleimide-polyethylene glycol-modified hemoglobin (MP4)

被引:35
作者
Drobin, D
Kjellstrom, BT
Malm, E
Malavalli, A
Lohman, J
Vandegriff, KD
Young, MA
Winslow, RM
机构
[1] Sangart Inc, San Diego, CA 92121 USA
[2] Univ Calif San Diego, Dept Bioengn, San Diego, CA 92093 USA
[3] Swedish Def Res Agcy, FOI, SE-17290 Stockholm, Sweden
[4] Sodersjukhuset Hosp, Karolinska Inst, Dept Anesthesiol, S-11883 Stockholm, Sweden
[5] Sodersjukhuset Hosp, Karolinska Inst, Dept Surg, S-11883 Stockholm, Sweden
关键词
polyethylene glycol; 4% maleimide polyethylene glycol hemoglobin; hemoglobin; shock; blood substitutes;
D O I
10.1152/japplphysiol.00530.2003
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Cell-free Hb increases systemic and pulmonary pressure and resistance and reduces cardiac output and heart rate in animals and humans, effects that have limited their clinical development as "blood substitutes." The primary aim of this study was to evaluate the hemodynamic response to infusion of several formulations of a new polyethylene glycol (PEG)-modified human Hb [maleimide PEG Hb (MalPEG-Hb)] in swine, an animal known to be sensitive to Hb-induced vasoconstriction. Anesthetized animals underwent controlled hemorrhage (50% of blood volume), followed by resuscitation (70% of shed volume) with 10% pentastarch ( PS), 4% MalPEG-Hb in lactated Ringer (MP4), 4% MalPEG-Hb in pentastarch (HS4), 2% MalPEG-Hb in pentastarch (HS2), or 4% stroma-free Hb in lactated Ringer solution (SFH). Compared with baseline, restoration of blood volume after resuscitation was similar and not significantly different for the PS (103%), HS2 (99%), HS4 (106%), and MP4 (87%) animals but significantly less for the SFH animals (66%) (P<0.05). All solutions that contained MalPEG-Hb restored mean arterial and pulmonary pressure and cardiac output. Systemic vascular resistance was unchanged, and pulmonary arterial pressure and resistance were increased slightly. Both systemic and pulmonary vascular resistance increased significantly in animals that received SFH, despite less adequate blood volume restoration. Oxygen consumption was maintained in all animals that received MalPEG-Hb, but not PS. Base excess improved only with MalPEG-Hb and PS, but not SFH. Red blood cell O-2 extraction was significantly increased in animals that received Hb, regardless of formulation. These data demonstrate resuscitation with MalPEG-human Hb without increasing systemic vascular resistance and support our previous observations in animals suggesting that the efficacy of low concentrations of PEG-Hb in the plasma results from reduced vasoconstriction.
引用
收藏
页码:1843 / 1853
页数:11
相关论文
共 41 条
[1]  
ACHARYA AS, 1996, HEMOGLOBIN CROSSLINK, P1
[2]   The ability of polyethylene glycol conjugated bovine hemoglobin (PEG-Hb) to adequately deliver oxygen in both exchange transfusion and top-loaded rat models [J].
Conover, CD ;
Linberg, R ;
Shum, KL ;
Shorr, RGL .
ARTIFICIAL CELLS BLOOD SUBSTITUTES AND IMMOBILIZATION BIOTECHNOLOGY, 1999, 27 (02) :93-107
[3]   PEG-hemoglobin as a resuscitation solution in the treatment of hypovolemic shock in the anesthetized rat [J].
Conover, CD ;
Linberg, R ;
Lejeune, L ;
Nagy, M ;
Shum, KL .
ARTIFICIAL ORGANS, 1999, 23 (12) :1088-1098
[4]   RESUSCITATION WITH DIASPIRIN CROSS-LINKED HEMOGLOBIN IN A PIG MODEL OF HEMORRHAGIC-SHOCK [J].
DUNLAP, E ;
FARRELL, L ;
NIGRO, C ;
ESTEP, T ;
MARCHAND, G ;
BURHOP, K .
ARTIFICIAL CELLS BLOOD SUBSTITUTES AND IMMOBILIZATION BIOTECHNOLOGY, 1995, 23 (01) :39-61
[5]   Effect of α-α diaspirin crosslinked hemoglobin (DCLHb™) on the potency of sodium nitroprusside and nitroglycerine to decrease blood pressure in rats:: A dose-response study [J].
Erhart, SM ;
Cole, DJ ;
Patel, PM ;
Drummond, JC ;
Burhop, KE .
ARTIFICIAL CELLS BLOOD SUBSTITUTES AND IMMOBILIZATION BIOTECHNOLOGY, 2000, 28 (05) :385-396
[6]  
*FDA CTR BIOL EV R, 1999, WORKSH CRIT SAF EFF
[7]   Plasma volume expansion with solutions of hemoglobin, albumin, and Ringer lactate in sheep [J].
Fischer, SR ;
Burnet, M ;
Traber, DL ;
Prough, DS ;
Kramer, GC .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 1999, 276 (06) :H2194-H2203
[8]   The first randomized trial of human polymerized hemoglobin as a blood substitute in acute trauma and emergent surgery [J].
Gould, SA ;
Moore, EE ;
Hoyt, DB ;
Burch, JM ;
Haenel, JB ;
Garcia, J ;
DeWoskin, R ;
Moss, GS .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 1998, 187 (02) :113-120
[9]  
GULATI A, 1994, J LAB CLIN MED, V124, P125
[10]   SYSTEMIC AND PULMONARY-HYPERTENSION AFTER RESUSCITATION WITH CELL-FREE HEMOGLOBIN [J].
HESS, JR ;
MACDONALD, VW ;
BRINKLEY, WW .
JOURNAL OF APPLIED PHYSIOLOGY, 1993, 74 (04) :1769-1778